Clinical Trial Update: A Phase III Study of Dasatinib vs Imatinib in Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia [Phase 3]

View source ↗

Summary

Phase III trial comparing dasatinib to imatinib in newly diagnosed chronic-phase chronic myeloid leukemia; results were posted in 2011. The study assesses wheth…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Gleevec (Imatinib)
• Sprycel (dasatinib)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Myeloid Leukemia, Chronic | Phase 3 | Status: COMPLETED | Results posted: 2011-03-15